Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

March 14, 2025

Study Completion Date

April 21, 2025

Conditions
Sexual Dysfunction, Physiological
Interventions
DRUG

20 mg estetrol monohydrate

Active treatment

OTHER

Placebo

Matching Placebo to E4

Trial Locations (24)

23456

Estetra Study Site, Virginia Beach

30328

Estetra Study Site, Atlanta

32256

Estetra Study Site, Jacksonville

32801

Estetra Study Site, Orlando

33173

Estetra Study Site, Miami

33409

Estetra Study Site, West Palm Beach

34562

Estetra Study Site, New Port Richey

34761

Estetra Study Site, Ocoee

38119

Estetra Study Site, Memphis

44106

Estetra Study Site, Cleveland

45322

Estetra Study Site, Englewood

60643

Estetra Study Site, Chicago

68114

Estetra Study Site, Omaha

77061

Estetra Study Site, Houston

77074

Estetra Study Site, Houston

84107

Estetra Study Site, Salt Lake City

85032

Estetra Study Site, Phoenix

85209

Estetra Study Site, Mesa

85715

Estetra Study Site, Tucson

87102

Estetra Study Site, Albuquerque

89109

Estetra Study Site, Las Vegas

91767

Estetra Study Site, Pomona

92111

Estetra Study Site, San Diego

98104

Estetra Study Site, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Estetra

INDUSTRY